Solutions / industries
KINGAI / AEGIS X

Pharmaceuticals & biotechnology

Lab records, regulated production, research IP

Pharmaceuticals & biotechnology

Risk & defense model

Protected assets

Lab records, regulated production, research IP

Risk scenarios

  • Research theft
  • data integrity loss
  • supplier risk

Proposed controls

Research isolation, change audit, signed records

Delivery & verification

Asset inventory, access matrix, evidence-based risk register, simulation report and reversible response plan. Verify in a separately authorized environment before implementation.

SYNTHETIC CASE STUDY

Research theft

Evidence

Scenario signal and contextual review; no real system data.

Control

Research isolation, change audit, signed records

Safety gate

Verify scope, identity, expiry, rollback and service health before authorized action.

Verification

Record approval, compare service checks, retain rollback evidence.

Proposed implementation flow

01 ObserveAuthorized telemetry & asset inventory
02 CorrelateEvidence, identity & threat context
03 DecidePolicy, safety gates & approval
04 VerifyReversible response & recovery

Illustrative design and synthetic data only. No live connections, production claims, customer logos or real response actions.